|
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RECRUITINGSponsored by Duke University
Actively Recruiting
SponsorDuke University
Started2015-07
Est. completion2028-06
Eligibility
Healthy vol.Accepted
Locations75 sites
View on ClinicalTrials.gov →
NCT02418442
Summary
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: 1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A). 2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures. 3. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff. Exclusion Criteria: 1\. Greater than 21 years of age at the time of enrollment.
Conditions2
ArthritisRheumatic Joint Disease
Locations75 sites
University of Alabama at Birmingham
Birmingham, Alabama, 35233
Phoenix Children's Hospital
Phoenix, Arizona, 85254
Children's Hospital of Los Angeles
Los Angeles, California, 90027
Mattel Children's Hospital at University of California Los Angeles
Los Angeles, California, 90095
Stanford University Medical Center
Palo Alto, California, 94304
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorDuke University
Started2015-07
Est. completion2028-06
Eligibility
Healthy vol.Accepted
Locations75 sites
View on ClinicalTrials.gov →
NCT02418442